
Similar Posts

The next big post-affirmative action legal ruling to drop targets billions in small business contracts
The Small Business Administration’s federal contracting program for socially and economically disadvantaged small businesses wasn’t a direct target of the U.S. Supreme Court decision earlier this year to effectively end race-conscious admission programs at colleges and universities. But it helped buoy the legal attacks against the SBA program, and more changes could be on the way…

‘Every detail matters’: Boeing CEO admits mistake as investigators probe midair panel blowout
Boeing CEO Dave Calhoun said the company acknowledges “our mistake,” after a door plug on a 737 Max 9 blew out in the middle of an Alaska Airlines flight, creating a gaping hole in the fuselage and prompting a grounding of that aircraft type by federal regulations. The Federal Aviation Administration grounded the 737 Max…
Article on Bill Ackman’s Wife Triggers Tensions Between Business Insider and Owner
Updated Jan. 9, 2024 8:22 pm ET Since acquiring Business Insider nine years ago, Axel Springer has largely steered clear of intervening in the news outlet’s editorial operations, even when high-profile people objected to unflattering articles about them. That hasn’t been the case in recent days. Copyright ©2024 Dow Jones & Company, Inc. All Rights…

Wedding Dress Designer Hayley Paige Says She’s Lost The Right To Her Instagram And Her Own Name In Court
Last week, JLM Couture sued the designer for breach of contract, among other things, in a New York federal court. The company’s main gripe is over the @misshayleypaige account, which JLM asserts it owns and has the right to operate as it sees fit. It also filed a temporary restraining order banning Gutman from using…

US inflation picks up more than expected in December
Prices rose by 3.4% as Americans paid more to dine out as well as on housing and car insurance.

Column: A new initiative by Biden that might finally bring drug prices down
The most frustrating thing about America’s failure to rein in drug prices is that a weapon against Big Pharma’s profiteering has been hiding in plain sight — and never used — for more than 40 years. But it’s now being unsheathed by the Biden White House. We’re talking about a provision of the Bayh-Dole Act…